JP2020534370A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020534370A5 JP2020534370A5 JP2020538517A JP2020538517A JP2020534370A5 JP 2020534370 A5 JP2020534370 A5 JP 2020534370A5 JP 2020538517 A JP2020538517 A JP 2020538517A JP 2020538517 A JP2020538517 A JP 2020538517A JP 2020534370 A5 JP2020534370 A5 JP 2020534370A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid substitution
- antibody
- modified
- iga2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023189702A JP2024023238A (ja) | 2017-09-21 | 2023-11-06 | 神経芽腫の治療のための抗ｇｄ２抗体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17192476.4 | 2017-09-21 | ||
| EP17192476 | 2017-09-21 | ||
| PCT/NL2018/050629 WO2019059771A2 (en) | 2017-09-21 | 2018-09-21 | ANTI-GD2 ANTIBODIES FOR THE TREATMENT OF NEUROBLASTOMA |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023189702A Division JP2024023238A (ja) | 2017-09-21 | 2023-11-06 | 神経芽腫の治療のための抗ｇｄ２抗体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020534370A JP2020534370A (ja) | 2020-11-26 |
| JP2020534370A5 true JP2020534370A5 (https=) | 2021-11-04 |
Family
ID=59955406
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020538517A Pending JP2020534370A (ja) | 2017-09-21 | 2018-09-21 | 神経芽腫の治療のための抗ｇｄ２抗体 |
| JP2023189702A Pending JP2024023238A (ja) | 2017-09-21 | 2023-11-06 | 神経芽腫の治療のための抗ｇｄ２抗体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023189702A Pending JP2024023238A (ja) | 2017-09-21 | 2023-11-06 | 神経芽腫の治療のための抗ｇｄ２抗体 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11866511B2 (https=) |
| EP (1) | EP3684818A2 (https=) |
| JP (2) | JP2020534370A (https=) |
| KR (1) | KR20200059249A (https=) |
| CN (1) | CN111278862A (https=) |
| AU (3) | AU2018336017B2 (https=) |
| BR (1) | BR112020005742A2 (https=) |
| CA (1) | CA3076482A1 (https=) |
| IL (1) | IL273454A (https=) |
| MX (1) | MX2020003201A (https=) |
| SG (1) | SG11202002581WA (https=) |
| WO (1) | WO2019059771A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114096559B (zh) * | 2019-03-27 | 2026-03-20 | 蒂嘉特克斯公司 | 工程化iga抗体及其使用方法 |
| CN111849904B (zh) * | 2020-07-31 | 2021-05-04 | 浙江科途医学科技有限公司 | 神经母细胞瘤类器官的培养基、培养方法及移植体 |
| EP4326292A4 (en) * | 2021-04-23 | 2025-03-26 | Vivasor, Inc. | Dimeric antigen receptors (dars) that bind gd2 |
| WO2024040194A1 (en) | 2022-08-17 | 2024-02-22 | Capstan Therapeutics, Inc. | Conditioning for in vivo immune cell engineering |
| AU2024279278A1 (en) | 2023-05-31 | 2025-12-18 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| EP4724490A2 (en) | 2023-06-12 | 2026-04-15 | Amgen Inc. | Lymphotoxin beta receptor agonist binding proteins |
| US20250127728A1 (en) | 2023-10-05 | 2025-04-24 | Capstan Therapeutics, Inc. | Constrained Ionizable Cationic Lipids and Lipid Nanoparticles |
| WO2025076113A1 (en) | 2023-10-05 | 2025-04-10 | Capstan Therapeutics, Inc. | Ionizable cationic lipids with conserved spacing and lipid nanoparticles |
| WO2025217452A1 (en) | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Constrained ionizable cationic lipids and lipid nanoparticles |
| WO2025217454A2 (en) | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Ionizable cationic lipids and lipid nanoparticles |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6284536B1 (en) | 1998-04-20 | 2001-09-04 | The Regents Of The University Of California | Modified immunoglobin molecules and methods for use thereof |
| US8236561B2 (en) | 1999-04-15 | 2012-08-07 | Crucell Holland B.V. | Efficient production of IgA in recombinant mammalian cells |
| PT1999154E (pt) | 2006-03-24 | 2013-01-24 | Merck Patent Gmbh | Domínios proteicos heterodiméricos modificados |
| EP1916257A1 (en) * | 2006-10-27 | 2008-04-30 | Charite-Universitätsmedizin Berlin | GD2 peptide mimotopes for anticancer vaccination |
| US8313730B2 (en) | 2006-12-13 | 2012-11-20 | Michael R. Simon | Treatment of celiac disease with IgA |
| EP2578681B1 (en) | 2010-05-24 | 2015-07-01 | Kagoshima University | Iga-binding peptide and iga purification using same |
| EP2465536A1 (en) | 2010-12-14 | 2012-06-20 | CSL Behring AG | CD89 activation in therapy |
| EP2791170A1 (en) | 2011-12-16 | 2014-10-22 | Synthon Biopharmaceuticals B.V. | Compounds and methods for treating inflammatory diseases |
| EP2636681A1 (en) | 2012-03-09 | 2013-09-11 | CSL Behring AG | Process for enriching IgA |
| BR112014022240A2 (pt) | 2012-03-09 | 2017-08-01 | Csl Behring Ag | composições compreendendo imunoglobulinas semelhantes à secretoras |
| WO2013189516A1 (en) * | 2012-06-18 | 2013-12-27 | Apeiron Biologics Ag | Method for treating a gd2 positive cancer |
| CN104736174B (zh) | 2012-07-06 | 2019-06-14 | 根马布私人有限公司 | 具有三重突变的二聚体蛋白质 |
| US9890216B2 (en) | 2012-10-23 | 2018-02-13 | Board Of Regents, The University Of Texas System | Antibodies with engineered IgG Fc domains |
| CN106414494B (zh) * | 2013-11-12 | 2020-09-18 | Ogd2药物 | 具有促凋亡活性的人IgG1衍生的抗体 |
| ES2768649T3 (es) * | 2013-11-21 | 2020-06-23 | Apeiron Biologics Ag | Preparaciones para tratar un cáncer positivo para GD2 |
| CN105732814B (zh) * | 2016-03-08 | 2019-05-28 | 苏州大学 | 抗人血管性血友病因子a3区的人鼠嵌合单克隆抗体及其制备方法和应用 |
| EP3747438A1 (en) | 2017-07-24 | 2020-12-09 | Stichting Het Nederlands Kanker Instituut- Antoni van Leeuwenhoek Ziekenhuis | Treating pathological conditions by direct and indirect targeting of sirpa - cd47 interaction |
-
2018
- 2018-09-21 EP EP18812321.0A patent/EP3684818A2/en active Pending
- 2018-09-21 JP JP2020538517A patent/JP2020534370A/ja active Pending
- 2018-09-21 CA CA3076482A patent/CA3076482A1/en active Pending
- 2018-09-21 AU AU2018336017A patent/AU2018336017B2/en active Active
- 2018-09-21 WO PCT/NL2018/050629 patent/WO2019059771A2/en not_active Ceased
- 2018-09-21 KR KR1020207011096A patent/KR20200059249A/ko not_active Ceased
- 2018-09-21 MX MX2020003201A patent/MX2020003201A/es unknown
- 2018-09-21 BR BR112020005742-8A patent/BR112020005742A2/pt not_active IP Right Cessation
- 2018-09-21 CN CN201880065543.8A patent/CN111278862A/zh active Pending
- 2018-09-21 SG SG11202002581WA patent/SG11202002581WA/en unknown
-
2020
- 2020-03-19 IL IL273454A patent/IL273454A/en unknown
- 2020-03-20 US US16/825,563 patent/US11866511B2/en active Active
- 2020-12-23 US US17/132,989 patent/US20210179732A1/en active Pending
-
2021
- 2021-09-23 AU AU2021236513A patent/AU2021236513A1/en not_active Abandoned
-
2023
- 2023-11-06 JP JP2023189702A patent/JP2024023238A/ja active Pending
-
2025
- 2025-02-26 AU AU2025201363A patent/AU2025201363A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020534370A5 (https=) | ||
| RU2458071C2 (ru) | Антитела-нейтрализаторы гранулоцитарно-макрофагального колониестимулирующего фактора человека | |
| JP2022031635A5 (https=) | ||
| JP2020513791A5 (https=) | ||
| JP2021501162A5 (https=) | ||
| JP2022101693A5 (https=) | ||
| JP2016536020A5 (https=) | ||
| JP2020514277A5 (https=) | ||
| JP2012530496A5 (https=) | ||
| JP2020508655A5 (https=) | ||
| JP2023134618A5 (https=) | ||
| JP2021514973A5 (https=) | ||
| JP2022516881A5 (https=) | ||
| JP2017535257A5 (https=) | ||
| JP2016507523A5 (https=) | ||
| JP2013519364A5 (https=) | ||
| JP2016505546A5 (https=) | ||
| RU2017102514A (ru) | Гуманизированные анти-тау-антитела | |
| JP2017534256A5 (https=) | ||
| US20250034273A1 (en) | Composition of multispecific antibodies targeting cadherin-17-expressing tumors and method of making and using thereof | |
| JP2022514734A5 (https=) | ||
| RU2013110874A (ru) | Антитела против il-18r1 и их применения | |
| JP2023509214A5 (https=) | ||
| JP7679399B2 (ja) | 抗ｆｌｔ３抗体及び組成物 | |
| JP2020513759A5 (https=) |